Aspect Biosystems Ltd.
Aspect Biosystems is a privately held biotechnology company combining the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics. By adopting Aspect™s microfluidic 3D bioprinting platform and collaborating within Aspect™s network, researchers worldwide are accelerating the development and commercialization of 3D bioprinted tissues. In addition, Aspect is advancing its internal regenerative medicine programs focused on metabolic diseases and musculoskeletal injuries and disorders and partnering with key industry players to bring bioprinted therapeutics to the clinic.
Who We Are
We are a bold team of innovators & entrepreneurs from all over the globe. Bringing together different backgrounds, perspectives, and expertise defines who we are and what we do.
What We Stand For
We believe that diversity drives disruptive ideas that will transform our health. We are passionate about collaborating with researchers and industry around the world to push the limits of our technology and make a real impact.
What We Do
We’ve combined the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics that will save lives and make people healthier.